Amphetamine- and scopolamine-induced locomotor activity following treatment with chlorphenvinphos or chlorphyriphos in rats

International Journal of Occupational Medicine and Environmental Health

Volumn 18, Issue 2, 2005, Pages 115-125

  Lutz, Piotr ^a   Gralewicz, Sławomir ^a   Kur, Barbara ^a   Wiaderna, Dorota ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

Amphetamine; Organophosphorous pesticides; Rat; Scopolamine

Indexed keywords

ACETYLCHOLINESTERASE; AMPHETAMINE; CHLORPYRIFOS; CLOFENVINFOS; ERYTHROCYTE ENZYME; ORGANOPHOSPHATE PESTICIDE; SCOPOLAMINE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; BEHAVIOR; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EXPOSURE; LOCOMOTION; MALE; NONHUMAN; RAT;

EID: 22844439550     PISSN: 12321087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Feldman RG. Organophosphorus compounds. In: Feldman RG, editor. Occupational and Environmental Neurotoxicology. New York: Lippincott-Raven; 1999. p.421-41.
2. Pope CN. Organophosphorus pesticides: Do they all have the same mechanism of toxicity? J Toxicol Environ Health 1999;2:161-81.
3. Eyer P. Neuropsychopathological changes by organophosphorus compounds - a review. Hum Exp Toxicol 1995;14:857-64.
4. Lotti M, Becker CE, Aminoff MJ. Organophosphate polyneuropathy: pathogenesis and prevention. Neurology 1995;34:658-62.
5. Lotti M, Moretto A. Promotion of organophosphate induced delayed polyneuropathy by certain esterase inhibitors. Chem Biol Interact 1999;119-120:519-24.
6. Gershon S, Shaw FH. Psychiatric sequelae of chronic exposure to organophosphorus insecticides. Lancet 1961;1:1371-4.
7. Metcalf DR, Holmes JH. EEG, psychological and neurological alterations in humans with organophosphorus exposure. Ann New York Acad Sci 1969;160:357-65.
8. Brown MA, Brix KA. Review of health consequences from high-, intermediate- and low-level exposure to organophosphorus nerve agents. J Appl Toxicol 1998;18:393-408.
9. Savage EP, Keefe TJ, Mounce LM, Heaton RK, Lewis JA, Burcar PJ. Chronic neurological sequele of acute organophosphate pesticide poisoning. Arch Environ Health 1988;43:38-45.
10. Rosenstock L, Keifer M, Daniel WE, McConnell R, Claypoole K. Chronic central nervous system effects of acute organophosphate pesticide intoxication. Lancet 1991;338:223-7.
11. Padilla S. The neurotoxicity of cholinesterase-inhibiting insecticides: past and present evidence demonstrating persistent effects. Inhalation Toxicol 1995;7:903-7.
12. Ray DE, Richards PG. The potential for toxic effects of chronic, low-dose exposure to organophosphates. Toxicol Lett 2001;120:343-51.
13. Duffy FH, Burchfiel JL, Bartels PH, Gaon M, Sim VM. Long-term effects of an organophosphate upon the human electroencephalogram. Toxicol Appl Pharmacol 1979;47:161-76.
14. Overstreet DH, Miller CS, Janowsky DS, Russel RW. Potential animal model of multiple chemical sensitivity with cholinergic supersensitivity. Toxicology 1996;111:119-34.
15. Gralewicz S, Lutz P, Szymczak W. Hyposensitivity to amphetamine following exposure to chlorphenvinphos. Protection by amphetamine preexposure. Acta Neurobiol Exp 2000;60:203-7.
16. Lutz P, Tomas T, Gralewicz S, Nowakowska E. Long-term effects of acute exposure to chlorphenvinphos on behavioural responsiveness to amphetamine and scopolamine in rats. Int J Occup Med Environ Health 2000;13:215-22.
17. Pope CN, Chakraborti TK, Chapman ML, Farrar JD. Long-term neurochemical and behavioral effects induced by acute chlorpyrifos treatment. Pharmacol Biochem Behav 1992;42:251-6.
18. Ellman GL, Courtney KD, Andres VJr, Feather-Stone RM. A new and rapid colonmetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
19. Socko R, Gralewicz S, Gorny R. Long-term behavioural effects of a repeated exposure to chlorphenvinphos in rats. Int J Occup Med Environ Health 1999;12:105-17.
20. Gralewicz S, Soćko R. Effects of a single exposure to chlorphenvinphos, an organophosphorous insecticide, on hot-plate behaviour in rats. Pol J Occup Med 1989;3:215-22.
21. Winer BJ. Statistical Principles in Experimental Design. New York: Mac Graw Hill Book Company; 1962.
22. Siegel S. Nonparametric Statistics for the Behavioral Sciences. New York: McGraw-Hill Bool Company;1956.
23. Nostrand AC, Padilla S, Moser VC. The relationship of oral chlorpyrifos effects on behavior, cholinesterase inhibition, and muscarinic receptor density in rat. Pharmacol Biochem Behav 1997;58:15-23.
24. Gordon ChJ, Watkinson WP. Strain differences in the laboratory rat: Impact on the autonomic, behavioral and biochemical response to cholinesterase inhibition. J Toxicol Environ Health 1995;45:59-73.
25. Won YK, Liu J, Olivier K, Zheng Q, Pope CN. Age-related effects of chlorpyrifos on acetylcholine release in rat brain. Neurotoxicology 2001;22:39-48.
26. Shih TM, Penetar DM, McDonough JH, Romano JA, King JM. Age-related differences in soman toxicity and in blood and brain regional cholinesterase activity. Brain Res Bull 1990;24:429-36.
27. Sachana M, Fiaskos J, Nikolaidis E, Hargreaves A, Alexaki-Tzivanidou E. Inhibition of rat platelet 5-hydroxydopamine uptake by chlorpyrifos and carbaryl. Pharmacol Toxicol 2001;89:195-200.
28. Gralewicz S, Tomas T, Soćko R. Interaction of chlorphenvinphos with cholinergic receptors in the rabbit hypothalamus. Neurotoxicol Teratol 1995;17:289-95.
29. Carvajal F, Sanchez-Amate MC, Sanchez-Santed F, Cubero I. Neuroanatomical targets of the organophosphate chlorpyrifos by c-fos immunolabeling. Toxicological Sciences 2005;84:1-8.
30. Dantzer R. Cytokine-induced sickness behavior: Mechanisms and implications. Ann NY Acad Sci 2001;933:222-34.
31. Antelman SM, Caggiula AR, Kocan D, Knopf S, Meyer D, Edwards DJ, et al. One experience with "lower" or "higher" stressors, respectively, enhances or diminishes responsiveness to haloperidol weeks later: implications for understanding drug variability. Brain Res 1991;566:276-83.
32. Antelman SM, Soares JC, Gershon S. Time-dependent sensitization - possible implications for clinical pharmacology. Behav Pharmacol 1997;8:505-14.
33. Shannon HE, Peters SC. A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice. J Pharmacol Exp Ther 1990;255:549-53.